Correction to: Scientific Reports https://doi.org/10.1038/srep20253, published online 02 February 2016
This Article contains errors in Figure 5.
As a result of an error in figure assembly, the representative image provided for NIF 25 mg/kg of Figure 5(e) is incorrect. The dot plot of Figure 5(f) has also been inadvertently duplicated from Figure 5(e). The correct Figure 5 and accompanying legend appear below.
Effects of nifuroxazide on tumor growth in vivo. Mice implanted with A375 xenografts were treated with 25 and 50 mg/kg/day when the tumors grew to about 100 mm3. (a) Tumor volumes were measured every 3 days and presented as mean ± SD (n = 6, *P < 0.05; **P < 0.01). (b) The bar charts of tumor weight. (c) Tumor cell proliferation was evaluated through immunohistochemical analysis staining with Ki67 and the statistical data of Ki67 positive cell number were shown on the right. (d) The apoptosis of tumor was determined by cleaved caspase-3 immunohistochemical staining and the statistical data of CC-3 positive cell number were shown on the right. Similarly, the immunohistochemical analysis was performed to measure the expressions of MMP-2 (e), MMP-9 (f) and p-Stat3 (g) in tumor tissues. P values for comparison of two groups were determined by 2-tailed Student’s t test (*P < 0.05; **P < 0.01; ***P < 0.001 vs vehicle control).
These changes do not affect the conclusions of the Article.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhu, Y., Ye, T., Yu, X. et al. Author Correction: Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma. Sci Rep 12, 10920 (2022). https://doi.org/10.1038/s41598-022-14642-8
Published:
DOI: https://doi.org/10.1038/s41598-022-14642-8
